Search

for
Search:

GlossaryTemsirolimus

medication that inhibits mTOR to treat advanced kidney cancer

Temsirolimus is a medication primarily used to treat advanced kidney cancer. It works by inhibiting a protein called mTOR, which plays a key role in cell growth and proliferation. By blocking this protein, Temsirolimus can help slow the growth of cancer cells.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 26 results

research Anticancer Drugs in Surface Waters

310 citations, November 2011 in “Environment International”

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

research Cutaneous Adverse Effects of Targeted Therapies

192 citations, February 2015 in “Journal of the American Academy of Dermatology”

Targeted cancer therapies often cause serious skin problems that need careful management.

research Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails

179 citations, October 2018 in “American Journal of Clinical Dermatology”

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

research Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal, and Prostate Cancer

45 citations, January 2020 in “International Journal of Molecular Sciences”

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

research Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies

44 citations, September 2015 in “Annals of Oncology”

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

View more "temsirolimus" in research →

Community Join

0 / 0 results

— no results